Xtalks发布精准肿瘤学生物标志物与数字数据方案免费网络研讨会预告

In this free webinar, learn how biomarker and next-generation sequencing strategies can improve patient identification, trial design and execution in precision oncology. The featured speakers will discuss decentralized and hybrid recruitment approaches, high-quality clinical endpoint data and the use of real-world evidence across the development lifecycle. Attendees will also explore how AI-enabled data extraction and linked clinical and genomic datasets can strengthen evidence generation and support access to targeted therapies.
TORONTO, July 31, 2026 /PRNewswire/ -- Precision oncology is transforming cancer care by enabling therapies to be matched to the molecular characteristics of individual patients. As biomarker-driven development expands across tumor types, sponsors face increasing challenges in identifying eligible patients, optimizing trial execution and generating the evidence needed to support regulatory, reimbursement and clinical decision-making.
This webinar will explore strategies for advancing precision oncology across the development lifecycle. Topics will include the evolving biomarker landscape and testing approaches, innovative methods for identifying and recruiting biomarker-eligible patients through decentralized and hybrid trial models and the growing role of high-quality clinical data and real-world evidence in accelerating development and demonstrating value.
The discussion will also highlight how AI-enabled data extraction, linked clinical and genomic datasets and modern evidence-generation strategies are helping sponsors gain deeper insights, improve trial efficiency and support broader adoption of precision therapies.
Register for this webinar to learn how precision oncology strategies can strengthen biomarker-driven patient identification, trial execution and evidence generation.
Join Mark Yates, MD, PhD, Director of RWE Strategy and RWD Solutions, PPD clinical research business, Thermo Fisher Scientific; Jai Balkissoon, MD, FACS, Global Vice President, Head Cell and Gene Therapy, Medical Science & Strategy, Oncology, PPD, clinical research business, Thermo Fisher Scientific; Ethel Pilati, Executive Director, Project Management, Precision Medicine in Oncology, Lead, PPD clinical research business, Thermo Fisher Scientific; Anu Bansal, MD, MS, VP, Head of Oncology, Medical Imaging, Endpoint Data, CLARIO, part of Thermo Fisher Scientific; Jane Li, Senior Director, Pharma and CRO, Life Sciences Solutions, Thermo Fisher Scientific; and Yarden Ginsburg, Senior Patient Recruitment & Engagement Lead, Patient First Digital Solutions, PPD Clinical Research Services, Thermo Fisher Scientific, for the live webinar on Thursday, August 20, 2026, at 11am EDT (5pm CEST / EU-Central).
For more information, or to register for this event, visit Advancing Precision Oncology with Biomarker-driven Strategies and Digital Data Solutions.
ABOUT XTALKS
Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.
Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.
To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/
Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]
SOURCE Xtalks